Equity Overview
Price & Market Data
Price: $303.6
Daily Change: +$26.25 / 8.65%
Daily Range: $286.7 - $325.0
Market Cap: $21,362,298,880
Daily Volume: 1,787,809
Performance Metrics
1 Week: 5.25%
1 Month: 2.05%
3 Months: 14.85%
6 Months: 6.62%
1 Year: 59.28%
YTD: 16.27%
Company Details
Employees: 3900
Sector: Health technology
Industry: Medical specialties
Country:
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.